Oral abstracts
| ESVC – European Society of Veterinary Cardiology | |||
| Thursday 18 September | |||
| 08.30 | ESVC-O-2 | Krofič Žel | Chronic inflammation is present in cats with cardiomyopathies |
| 08.45 | ESVC-O-3 | Brown | Quality of life assessment in dogs with atrial fibrillation: the optimal rate control in dogs with atrial fibrillation IV study |
| 09.00 | ESVC-O-4 | Bagardi | Variation of QRS complex configuration in 12-lead electrocardiogram in Doberman Pinchers with dilated cardiomyopathy |
| 09.15 | ESVC-O-5 | van de Watering | Feasibility of a new minimally invasive implantable cardiac monitor for remote heart rhythm monitoring in dogs and a cat |
| 09.30 | ESVC-O-6 | Cofaru | Assessment of arrhythmias in healthy cats using holter monitoring: A cross-sectional study |
| 09.45 | ESVC-O-8 | Peres de Thomaz | Left ventricular strain imaging to evaluate cardiac function in dogs eating pulse inclusive diets |
| 10.00 | ESVC-O-9 | Legrand | Evaluation of different right heart parameters for the diagnosis of precapillary pulmonary hypertension in dogs with chronic respiratory disorders: a prospective study |
| 11.20 | ESVC-O-10 | Crosland | Echocardiographic feline left atrial appendage assessment |
| 11.35 | ESVC-O-11 | Grosso | Echocardiographic reference intervals for the right pulmonary artery size and distensibility index in 164 healthy cats |
| 11.50 | ESVC-O-12 | Sehn | Impact of including or excluding endocardial borders on left ventricular wall thickness measurements in cats |
| 12.05 | ESVC-O-13 | Novo Matos | Contrast-enhanced echocardiographic assessment of left ventricular wall measurements in cats |
| 12.20 | ESVC-O-14 | Novo Matos | Understanding transient myocardial thickening in cats: a global survey of veterinary cardiologists |
| 12.35 | ESVC-O-15 | Allan | The influence of sex on left ventricular gene expression in healthy cats |
| Friday 19 September | |||
| 09.00 | ESVC-O-16 | Scurtu | Efficacy of a slow-kill protocol, moxidectine and imidacloprid with and without doxycycline, to eliminate Dirofilaria immitis in dogs |
| 09.15 | ESVC-O-17 | Szatmári | Perioperative antimicrobial prophylaxis protocols in dogs undergoing catheter-based cardiac interventions and transvenous pacemaker implantation – results of a worldwide survey |
| 09.30 | ESVC-O-18 | Szatmári | Correlation between chronic cough and radiographic signs of bronchial compression in dogs with cardiomegaly secondary to severe mitral valve regurgitation |
| 09.45 | ESVC-O-19 | Melis | Genotyping the nebulette risk variants in Cavalier King Charles Spaniel breeding dogs |
| 10.00 | ESVC-O-20 | Rishniw | Does increasing left atrial enlargement or congestive heart failure in dogs with mitral valve disease increase the likelihood of coughing? |
| 10.15 | ESVC-O-21 | Miralles-Plaza | Long-term efficacy and safety of torasemide in dogs with congestive heart failure secondary to myxomatous mitral valve disease stage C |
| 11.20 | ESVC-O-22 | Apolloni | Clinical findings and survival time in dogs with myxomatous mitral valve disease at the American College of Veterinary Internal Medicine stage D |
| 11.35 | ESVC-O-23 | Rishniw | A modified mitral insufficiency echocardiographic score differentiates severities of subclinical mitral valve disease |
| 11.50 | ESVC-O-24 | Showers | Assessing indices of left atrial size in Cavalier King Charles Spaniels before and after the development of mitral valve regurgitation |
| 12.05 | ESVC-O-25 | Patata | Left atrial volume measured by monoplane Simpson’s method of disk in healthy small breed dogs and dogs affected by myxomatous mitral valve disease |
| 12.20 | ESVC-O-26 | Alibrandi | Lipofuscin-rich extracellular vesicles adjusted to body weight as biomarkers of oxidative stress in canine myxomatous mitral valve disease |
| 12.35 | ESVC-O-27 | Borgarelli | Survival characteristics and prognostic variables in dogs with presymptomatic myxomatous mitral valve disease enrolled in the longitudinal outcome of canine myxomatous mitral valve disease study |
| 16.30 | ESVC-O-28 | Padrosa Sala | Right ostium of the pulmonary vein distensibility index in dogs with myxomatous mitral valve disease |
| 16.45 | ESVC-O-29 | Isayama | Risk factors and outcomes following mitral valve repair in 112Dogs: a retrospective study |
| 17.00 | ESVC-O-30 | McAulay | Prognostic utility of mitral regurgitant fraction and doppler estimation of mitral regurgitation severity in dogs with myxomatous mitral valve |
| 17.15 | ESVC-O-31 | Guillot | Proteomic profiling reveals dose-dependent anti-inflammatory and anti-fibrotic effects of benazepril/spironolactone combination therapy in dogs |
| 17.30 | ESVC-O-32 | Frizzo-Ramos | Comparative analysis of iron parameters in dogs with congestive heart failure and healthy dogs |
| 17.45 | ESVC-O-33 | Malcolm | Variability of radiographic cardiac measurements measured by artificial intelligence-assisted software in dogs |
| SCH – Society of Comparative Hepatology | |||
| Thursday 18 September | |||
| 09.15 | SCH-O-1 | den Boer | Effect of the ATP7A and ATP7B gene variants on treatment response in Labrador Retrievers with hepatic copper accumulation |
| 09.30 | SCH-O-2 | Jaffey | Diagnostic performance of computed tomography to detect gallbladder rupture in dogs with gallbladder mucocele undergoing cholecystectomy |
| 09.45 | SCH-O-3 | Kéfer | Hepatic histological abnormalities in dogs with gallbladder mucocele and/or cholecystitis: a retrospective study based on 66 cases (2019-2025) |
| 10.00 | SCH-O-4 | Devriendt | The lidocaine/monoethylglycinexylydide test is a valuable alternative to Protein C activity to determine shunt closure after surgical attenuation of extrahepatic portosystemic shunts in dogs |
| 10.15 | SCH-O-5 | Rees | Gastrointestinal bleeding in dogs with portosystemic shunts: a retrospective, single centre study |
| ESVNU – European Society of Veterinary Nephrology and Urology | |||
| Thursday 18 September | |||
| 09.00 | ESVNU-O-1 | Li | Integrated landscape of renal metabolism in domestic cats with spontaneous chronic kidney disease: a multi-omics study |
| 09.15 | ESVNU-O-2 | Lötter | The effect of magnesium supplemented phosphate restricted diet in managing diet-induced hypercalcaemia in cats with chronic kidney disease |
| 09.30 | ESVNU-O-3 | Bestwick | Orthophosphate is liberated by feline intestinal alkaline phosphatase with different efficiencies from various dietary sources of inorganic phosphate |
| 09.45 | ESVNU-O-4 | Couronné | Pharmacodynamic efficiency of benazepril in a medicated diet for cats with chronic kidney disease |
| 10.00 | ESVNU-O-5 | Le Corre | Impact of subclinical bacteriuria on disease progression and survival in cats with chronic kidney disease: a multicenter retrospective study |
| 10.15 | ESVNU-O-6 | Logtenberg | Prevalence of ectopic ureters in a population of 551 Dutch assistance dogs screened with abdominal ultrasound |
| 11.20 | ESVNU-O-7 | Montier | Use of narrow-band imaging endoscopy in the detection and diagnosis of urogenital diseases in dogs: a preliminary study |
| 11.35 | ESVNU-O-8 | Morris | Validation of the VERI-5® system for rapid and accurate detection of animal isolates from clinical urine samples using NANOPLEX® technology |
| 11.50 | ESVNU-O-9 | Lunet Marques | Characterization of the hypothalamic-pituitary-adrenal axis in cats with chronic kidney disease and possible effect on kidney function |
| Friday 19 September | |||
| 09.30 | ESVNU-O-11 | Benoit | Sodium dodecyl sulfate-agarose gel electrophoresis in canine proteinuric chronic kidney disease: a potential predictive tool for disease progression and survival |
| 09.45 | ESVNU-O-13 | Coates | Investigation of circulating concentrations of microRNA-21 as potential biomarker for dogs with chronic kidney disease. |
| 10.00 | ESVNU-O-14 | Cornish | Fibroblast growth factor 23 concentrations in cats with ureteric obstruction |
| 10.15 | ESVNU-O-15 | Dreller | Clinical utility of two adenosine triphosphate-based rapid food hygiene tests for the detection of bacteriuria in dogs |
| ESVCP - European Society of Veterinary Clinical Pathology | |||
| Thursday 18 September | |||
| 14.25 | ESVCP-O-1 | Niederlender | Reference intervals of urinary metanephrines to creatinine ratios in dogs: comparison of acidified and non-acidified samples collected by cystocentesis |
| 14.40 | ESVCP-O-2 | Doulidis | Clot Pro thromboelastography in canine coagulation disorders: A retrospective analysis |
| 14.55 | ESVCP-O-3 | Thenard | Diagnostic accuracy of effusion protein concentration, cellularity, and effusion-to-serum protein ratio for classifying pleural and abdominal effusions in dogs and cats: A retrospective study of 236 cases |
| 15.10 | ESVCP-O-4 | Lodarski | Evaluation of plasma aspartate aminotransferase activity as biomarker and prognostic factor in feline liver diseases |
| 15.25 | ESVCP-O-5 | Wiesner | Establishing liquid chromatography-tandem mass spectrometry-based reference intervals for T4, T3, and reverse T3 in healthy dogs and their correlation with chemiluminescence assays |
| 15.40 | ESVCP-O-6 | von Luckner | Introducing novel diagnostics for detecting coumarin activity by high-pressure-liquid-chromatography coupled to tandem-mass-spectrometry |
| 15.55 | ESVCP-O-7 | Morini | Acute phase proteins in naturally occurring Addison's disease at diagnosis and 48 hours post-treatment |
| 16.10 | ESVCP-O-8 | Museux | Validation of a new quick and high throughput latex agglutination immuno-assay for feline alpha-1-acid glycoprotein |
| 16.25 | ESVCP-O-9 | Petibon | Variability of renin-angiotensin-aldosterone system biomarkers: spontaneous fluctuations in healthy cats and hydration status-related changes in sick cats |
| ESCG – European Society of Comparative Gastroenterology | |||
| Friday 19 September | |||
| 09.00 | ESCG-O-1 | Pilla | Assessment of Peptacetobacter hiranonis genome and its in vitro ability to convert bile acids – a promising microbial-based therapy for companion animals |
| 09.15 | ESCG-O-2 | Bouillet | CD3+ lymphocytes and canine intestinal inflammation: insights from an expanded cohort |
| 09.30 | ESCG-O-3 | Rudinsky | Risk and relationship between antibiotic exposures and development of chronic enteropathy in adult dogs |
| 09.45 | ESCG-O-4 | Barko | Microbial indole catabolites of tryptophan and enteric microbiota dysbiosis in dogs with chronic enteropathy |
| 10.00 | ESCG-O-5 | Farges | Assessment of hypercoagulability using rotational thromboelastometry in dogs with chronic enteropathy |
| 10.15 | ESCG-O-6 | Moraiti | Histopathologic evaluation of endoscopic biopsies of the gastrointestinal tract in healthy older cats-are they really healthy? |
| 10.30 | ESCG-O-7 | Moraiti | Association between endoscopic and histopathologic findings, final diagnosis and clinical severity in cats with chronic enteropathy |
| 11.20 | ESCG-O-8 | Wright | Comparison of clinicopathologic, imaging and outcome variables in feline gastrointestinal eosinophilic sclerosing fibroplasia and its disease mimics. |
| 11.35 | ESCG-O-9 | Thenard | Clinical, laboratory and ultrasonographic variables differentiating eosinophilic enteritis from lymphoplasmacytic enteritis in cats: a retrospective study of 113 cases |
| 11.50 | ESCG-O-10 | Halka | Clinical presentation and outcome of 61 dogs with eosinophilic gastrointestinal inflammation identified on endoscopic biopsy histopathology |
| 12.05 | ESCG-O-11 | Alonzo | Long-term follow-up in dogs with protein-losing enteropathy treated with dietary fat restriction |
| 12.20 | ESCG-O-12 | Toresson | Fecal microbiota transplantation as adjunct treatment in dogs with chronic enteropathies – a prospective study |
| 12.35 | ESCG-O-13 | Montanes Sancho | Assessment of the clinical efficacy of an intense faecal microbiota transplantation protocol in dogs with acute haemorrhagic diarrhoea syndrome |
| 12.50 | ESCG-O-14 | Kyriakopoulou | Prokinetic effect of erythromycin for treating delayed gastric emptying in dogs |
| ESVIM – European Society of Veterinary Internal Medicine | |||
| Thursday 18 September | |||
| 15.55 | ESVIM-O-1 | Yu | Hyperbilirubinaemia and bilirubin encephalopathy in dogs with non-associative immune mediated haemolytic anaemia |
| 16.10 | ESVIM-O-2 | Hebert | Epidemiological, clinical and prognostic features of non-associative and associative immune-mediated hemolytic anemia in cats: a multicentric retrospective study of 92 cases |
| 16.25 | ESVIM-O-3 | Giampaolo | Clinical and diagnostic findings, and outcome in 52 cats with nonregenerative anemia due to pure red cell aplasia or precursor-targeted immune-mediated anemia |
| 16.40 | ESVIM-O-4 | Alsteens | Prevalence of tachypnea and/or acute respiratory distress secondary to packed red blood cell transfusion in cats and association with survival |
| Friday 19 September | |||
| 14.40 | ESVIM-O-6 | Huang | Applying low-frequency manual jet ventilation for bronchoscopic examination in clinical dogs |
| 14.55 | ESVIM-O-7 | Rösch | New insights into canine idiopathic rhinitis |
| 15.10 | ESVIM-O-8 | Chang | Long-term follow-up of canine bronchomalacia after bronchoscopy: Survival and prognostic factors in dogs |
| 15.25 | ESVIM-O-9 | Robinne | Prospective assessment of focused cardiac ultrasound by non-cardiologists to detect canine pre-capillary pulmonary hypertension in dogs with chronic respiratory disease |
| 15.40 | ESVIM-O-10 | Lyssens | Detection of neutrophilic extracellular traps in bronchoalveolar lavage fluid of healthy dogs and of dogs with bronchiectasis, bronchomalacia and bacterial bronchopneumonia |
| 16.30 | ESVIM-O-11 | Gareis | Evaluation of the acute-phase proteins serum amyloid A and haptoglobin in cats with respiratory disease |
| 16.45 | ESVIM-O-12 | Seedat | Serum amyloid A in cats with systemic inflammatory response syndrome, sepsis and feline infectious peritonitis |
| 17.00 | ESVIM-O-13 | Doyle | Aetiology and diagnosis of pyogranulomatous and neutrophilic lymphadenitis in cats presenting to a referral hospital: a retrospective review of 71 cases |
| 17.15 | ESVIM-O-14 | Pandya | Prevalence of gastrointestinal hemorrhage in dogs treated with high dose corticosteroids assessed with video capsule endoscopy: a pilot study |
| 17.30 | ESVIM-O-15 | Pradera | Equine umbilical cord mesenchymal stem cells demonstrate safety and efficacy in the treatment of canine inflammatory bowel disease: a randomized placebo-controlled trial |
| 17.45 | ESVIM-O-16 | Zdyrski | Multi-tissue characterization of canine organoids for disease modeling and therapeutic drug screening in veterinary internal medicine |
| ESVONC – European Society of Veterinary Oncology | |||
| Friday 19 September | |||
| 14.25 | ESVONC-O-1 | Maga | Dose and duration of upfront steroid administration have no prognostic impact in dogs with multicentric diffuse large B-cell lymphoma |
| 14.40 | ESVONC-O-2 | Ng | Comparison of adrenal cytology and histopathology in dogs and cats: A retrospective multicentre study |
| 14.55 | ESVONC-O-3 | Fejös | Canine pelvic osteosarcoma: a retrospective multicenter study of 24 dogs |
| 15.10 | ESVONC-O-4 | Zdyrski | The canine urothelial carcinoma organoid biobank: A resource for translational research |
| 15.25 | ESVONC-O-5 | Buisset | Retrospective evaluation of a lomustine, vincristine, procarbazine and prednisolone-based protocol for first line treatment of canine naïve high grade multicentric T cell lymphoma |
| 15.40 | ESVONC-O-6 | Ronel | MicroRNA expression in histiocytic sarcomas of flat-coated retrievers |
| 16.30 | ESVONC-O-9 | Turchi | Histologic grade, but not subtype, influences tumor progression in dogs with appendicular osteosarcoma |
| 16.45 | ESVONC-O-11 | Mochel | Innovative in vitro–in silico platform for dose-response modeling in canine bladder cancer: A 3D organoid- and mathematics-based approach |
| 17.00 | ESVONC-O-10 | McCarthy | Evaluation of the tolerability and outcomes of a single infusion of streptozocin in the management of canine insulinoma |
| 17.15 | ESVONC-O-12 | Zaniboni | Use of propranolol in combination with chemotherapy in dogs with inoperable and/or metastatic hemangiosarcoma |
| 17.30 | ESVONC-O-13 | Freiche | Assessment of O-N-acetylglucosaminylation in colorectal extracellular vesicles of dogs: a preliminary prospective study |
| ISCAID – International Society for Companion Animal Infectious Diseases | |||
| Saturday 20 September | |||
| 08.00 | ISCAID-O-1 | Carranza Valencia | Phylogenetic analysis of feline coronavirus strains from a cohort of cats with feline infectious peritonitis in Switzerland |
| 08.15 | ISCAID-O-2 | Zwicklbauer | Gene expression profiles of cats with feline infectious peritonitis before and during effective treatment |
| 08.30 | ISCAID-O-3 | Renner | Comparing the pharmacokinetics of GS-441524 following intravenous and oral administration of compounded remdesivir in cats with feline infectious peritonitis in New Zealand |
| 08.45 | ISCAID-O-4 | Meunier | Taking on the challenge: outcomes and monitoring of a 42-day GS-441524 treatment in cats with feline infectious peritonitis-associated neurological signs |
| 14.25 | ISCAID-O-5 | de Witt Curtius | Renal health in cats with feline infectious peritonitis: baseline findings and longitudinal effects of GS-441524 treatment |
| 14.40 | ISCAID-O-6 | Wenk | Exploring co-infections: the role of uncommon and novel viruses in cats with feline infectious peritonitis |
| 14.55 | ISCAID-O-7 | Jaffey | Diagnostic performance of anti-Coccidioides spp. antibody serology to predict dissemination in dogs with coccidioidomycosis |
| 15.10 | ISCAID-O-8 | Cheung | A retrospective study of oomycosis in domesticated animals in Australia over 25 years (1999-2024) |
| 15.25 | ISCAID-O-9 | Museux | Towards a new understanding of canine leptospirosis: clinical, genomic and epidemiology study of 925 cases between 2020 to 2024 in France |
| 15.40 | ISCAID-O-10 | Schäfer | Clinical signs, hematological findings, and treatment success in cats with feline granulocytic anaplasmosis in Europe (2022-2025) |
| 16.30 | ISCAID-O-11 | O'Halloran | Temporal cluster of feline tuberculosis cases caused by Mycobacterium caprae infection in England and Scotland associated with consumption of a raw meat-based diet |
| 16.45 | ISCAID-O-12 | Biernat | Does the cat with an abscess need an antibiotic? A retrospective study on outcomes in cutaneous and subcutaneous abscesses in cats treated without antibiotics |
| 17.00 | ISCAID-O-13 | Vlassenbroek | Management and outcomes of a virulent systemic feline calicivirus infection outbreak in a veterinary teaching hospital in Belgium |
| 17.15 | ISCAID-O-14 | Geisen | Hepatozoon species infections in cats living across Europe: molecular characterization and association with origin, clinical signs, coinfections, and clinicopathological abnormalities |
| 17.30 | ISCAID-O-15 | Watson | Electron microscopy of platelet activation and fragmentation during thrombus formation in dogs with Babesia rossi infection |
| 17.45 | ISCAID-O-16 | Carrasco-Martin | Prevalence of drug-resistance biomarkers in leishmania infantum clinical samples from the mediterranean |
| ESVE – European Society of Veterinary Endocrinology | |||
| Saturday 20 September | |||
| 08.15 | ESVE-O-1 | Lunet Marques | Urinary metanephrines in cats – does collection method matter? |
| 08.30 | ESVE-O-2 | Kurtz | Triple-A analysis of the renin-angiotensin-aldosterone system: establishment of reference intervals and application to the diagnosis of primary hyperaldosteronism in cats |
| 08.45 | ESVE-O-3 | Vassallo | Application of inflammatory hematological ratios in differentiating adrenal tumours in dogs |
| 09.00 | ESVE-O-4 | Del Baldo | Agreement between adrenal cytology and plasma/urinary free metanephrines in dogs with adrenal tumors |
| 09.15 | ESVE-O-5 | Arrigoni | Evaluating plasma renin activity as a monitoring parameter for mineralocorticoid therapy in dogs with primary hypoadrenocorticism |
| 09.30 | ESVE-O-6 | Nagata | Urinary corticoid-to-creatinine ratio combined with pre-trilostane cortisol for monitoring trilostane treatment in dogs with hypercortisolism |
| 09.45 | ESVE-O-7 | Tagliasacchi | Efficacy of trilostane treatment in reducing proteinuria secondary to canine spontaneous hypercortisolism |
| 10.00 | ESVE-O-8 | Boretti | Effects of prednisolone on canine thyroid axis using thyrotropin-releasing hormone stimulation testing and high-performance liquid chromatography-tandem mass spectrometry quantification of T4, T3 and rt3 |
| 10.15 | ESVE-O-9 | Teyssandier | Use of thyrotropin-releasing hormone-stimulated serum thyrotropin concentrations in dogs: A clue for sub-clinical hypothyroidism? |
| 11.20 | ESVE-O-10 | Corsini | Diagnostic performances of serum reverse triiodothyronine concentrations in dogs evaluated for suspected hypothyroidism |
| 11.35 | ESVE-O-11 | Pollicino | Urinary excretion of thyroxine in dogs with proteinuria |
| 11.50 | ESVE-O-12 | Flanagan | A pair-matched 1:3 case-control study of the potential association between prior obesity and diabetes mellitus in dogs |
| 12.05 | ESVE-O-13 | Rossi | Efficacy and safety of protamine zinc insulin administered once daily in newly diagnosed diabetic dogs monitored with flash glucose monitoring system |
| 12.20 | ESVE-O-14 | Bjørnvad | Effect of 12-week, intentional caloric restriction, using a novel therapeutic diabetic diet suitable for weight reduction, on glycaemic control in overweight cats with diabetes mellitus: an international prospective, randomised clinical trial |
| 12.35 | ESVE-O-15 | Mishra | Big news for big diabetic cats: sodium-glucose co-transporter-2 inhibitors in feline hypersomatotropism/acromegaly |
| ESVCN – European Society of Veterinary Comparative Nutrition | |||
| Saturday 20 September | |||
| 14.25 | ESVCN-O-1 | Hall | Impact of varying the Ca:P ratio in therapeutic renal foods on ionized calcium and regulation of calcium homeostasis in cats with early-stage renal disease: A preliminary report |
| 14.40 | ESVCN-O-3 | Nixon | Effects of probiotic and postbiotic Bifidobacterium animalis subspecies lactis CECT 8145 on markers of metabolic health in dogs during weight gain and weight loss |
| 14.55 | ESVCN-O-4 | Turnbull | Variables causally associated with hair cortisol concentration in dogs with obesity |
| 15.10 | ESVCN-O-5 | Brozic | Evaluation of the nutritional management protocol in dogs with chronic enteropathies |
| 15.25 | ESVCN-O-6 | Vecchiato | Clinical and faecal parameters of adult dogs with chronic enteropathy fed a hydrolised protein diet fortified or not with a probiotic strain |
| 15.40 | ESVCN-O-7 | Key | Hydrolyzed protein food with a specialized prebiotic fiber blend improves signs of pruritic dermatitis and stool quality in adult dogs |